Undisclosed glioblastoma oncolytic virus therapeutic
/ Rosalind Franklin University, U.P. Oncolytics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 23, 2024
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Rosalind Franklin University Helix 51 Company
(PRNewswire)
- "U.P. Oncolytics...has been awarded Orphan Drug designation by the FDA's Office of Orphan Products Development for its oncolytic virus-based therapy to treat malignant glioma."
Orphan drug • Glioma • Oncology
1 to 1
Of
1
Go to page
1